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Background:  Implantable cardioverter-defibrillator (ICD) therapy is a lifesaving intervention for patients with systolic heart failure. 
However, once implanted, limited data exist on physiological markers to predict appropriate ICD discharge. Therefore, strategies to better 
define patients at high risk for arrhythmia requiring ICD therapy are needed.
methods:  A retrospective single-institution investigation was designed to identify the echocardiographic parameters associated with 
appropriate ICD discharge among subjects with systolic heart failure. A total of 1,497 patients who underwent two-dimensional Doppler 
echocardiography within 90 days of an antecedent clinic visit were included in this study; of these, 53 patients had appropriate ICD 
discharge while 1,444 had no ICD discharge. Wilcoxon rank-sum tests were used to compare these two groups.
results:  Echocardiographic parameters associated with ICD shock vs. no ICD shock included left ventricular end-diastolic (LVED)-
dimension (6.1 ± 0.9 vs. 5.6 ± 1.0 cm, P=0.0001), left ventricular mass (284.7 ± 93.7 vs. 256.1 ± 94.0 g, P=0.02), and LVED-volume (194.2 
± 61.5 vs. 161.5 ± 63.0 mL, P=0.0001). The two groups did not differ in measures of systolic function, including stroke volume (60.1 ± 26.7 
vs. 55.4 ± 23.7 mL, P=0.2) and cardiac output (4.3 ± 1.7 vs. 4.0 ± 1.8 L/min, P=0.1), except for ejection fraction, which was statistically 
different (29.5 ± 13.0 vs. 37.0 ± 14.5, P=0.0002). For diastolic Doppler measures, shorter deceleration time (186.1 ± 74.3 vs. 216.6 ± 78.4 
ms, P=0.002), greater E/A ratio (1.7 ± 1.1 vs. 1.3 ± 0.9, P=0.02) and higher estimated pulmonary artery systolic pressure (46.6 ± 15.1 vs. 
38.1 ± 13.8 mmHg, P<0.0001) were significantly associated with ICD discharge.
conclusion:  Echocardiographic parameters reflecting severe diastolic abnormalities and significant ventricular remodeling are associated 
with appropriate ICD discharge. Most measures of systolic function did not show a similar association. Prospective validation of a risk score 
incorporating diastolic Doppler echocardiographic parameters may be useful to estimate risk associated with future ICD discharge.
